Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1951 1
1955 1
1979 1
1980 1
1982 1
1984 1
1989 2
1999 3
2000 2
2001 1
2002 1
2003 3
2004 7
2005 8
2006 8
2007 5
2008 7
2009 5
2010 6
2011 12
2012 8
2013 9
2014 12
2015 17
2016 15
2017 15
2018 11
2019 13
2020 12
2021 13
2022 10
2023 7
2024 12
2025 6
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

217 results

Results by year

Filters applied: . Clear all
Page 1
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Zhu AX, Kang YK, Yen CJ, Finn RS, Galle PR, Llovet JM, Assenat E, Brandi G, Pracht M, Lim HY, Rau KM, Motomura K, Ohno I, Merle P, Daniele B, Shin DB, Gerken G, Borg C, Hiriart JB, Okusaka T, Morimoto M, Hsu Y, Abada PB, Kudo M; REACH-2 study investigators. Zhu AX, et al. Among authors: rau km. Lancet Oncol. 2019 Feb;20(2):282-296. doi: 10.1016/S1470-2045(18)30937-9. Epub 2019 Jan 18. Lancet Oncol. 2019. PMID: 30665869 Clinical Trial.
Sequence-specific targeting of RNA.
Rösner L, Reichert D, Rau K, Muthmann N, Rentmeister A. Rösner L, et al. Among authors: rau k. Methods. 2022 Sep;205:73-82. doi: 10.1016/j.ymeth.2022.06.007. Epub 2022 Jun 25. Methods. 2022. PMID: 35764247
Clinical Outcomes and Histologic Findings of Patients With Hepatocellular Carcinoma With Durable Partial Response or Durable Stable Disease After Receiving Atezolizumab Plus Bevacizumab.
Shen YC, Liu TH, Nicholas A, Soyama A, Yuan CT, Chen TC, Eguchi S, Yoshizumi T, Itoh S, Nakamura N, Kosaka H, Kaibori M, Ishii T, Hatano E, Ogawa C, Naganuma A, Kakizaki S, Cheng CH, Lin PT, Su YY, Chuang CH, Lu LC, Wu CJ, Wang HW, Rau KM, Hsu CH, Lin SM, Huang YH, Hernandez S, Finn RS, Kudo M, Cheng AL. Shen YC, et al. Among authors: rau km. J Clin Oncol. 2024 Dec;42(34):4060-4070. doi: 10.1200/JCO.24.00645. Epub 2024 Aug 28. J Clin Oncol. 2024. PMID: 39197119 Free PMC article.
Deglycosylated PD-L1 is a biomarker for immune checkpoint blockade response: a real-world study in breast cancer patients in Taiwan.
Wang SC, Shen YC, Pan MR, Ou-Yang F, Liao TY, Liu LC, Rau KM, Lu LS, Huang CC, Dai MS, Lu YS, Chang HW, Chang H, Chang KP, Wang J, Tsai CJ, Chou IW, Li HW, Cheng WC, Li TC, Cha TL, Liao GS, Chiu CF, Huang CS, Tseng LM, Chiou JF, Sheen-Chen SM, Hou MF, Hung MC. Wang SC, et al. Among authors: rau km. Cancer Lett. 2025 Oct 28;631:217912. doi: 10.1016/j.canlet.2025.217912. Epub 2025 Jul 10. Cancer Lett. 2025. PMID: 40651655
The methamphetamine experience: a NIDA partnership.
Hanson GR, Rau KS, Fleckenstein AE. Hanson GR, et al. Among authors: rau ks. Neuropharmacology. 2004;47 Suppl 1:92-100. doi: 10.1016/j.neuropharm.2004.06.004. Neuropharmacology. 2004. PMID: 15464128 Review.
Making the Message Clear: Concepts for mRNA Imaging.
Rau K, Rentmeister A. Rau K, et al. ACS Cent Sci. 2017 Jul 26;3(7):701-707. doi: 10.1021/acscentsci.7b00251. Epub 2017 Jul 6. ACS Cent Sci. 2017. PMID: 28776011 Free PMC article. Review.
Comment on: Abdominal Emergencies in Cancer Patients.
Chiu SF, Rau KM, Chen CC, Chiu CC. Chiu SF, et al. Among authors: rau km. Can Assoc Radiol J. 2024 May;75(2):435-436. doi: 10.1177/08465371231211280. Epub 2023 Nov 20. Can Assoc Radiol J. 2024. PMID: 37982318 No abstract available.
217 results